Capital Research Global Investors Acquires 7,716 Shares of CME Group Inc. $CME

Capital Research Global Investors raised its holdings in CME Group Inc. (NASDAQ:CME) by 0.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,062,343 shares of the financial services provider’s stock after purchasing an additional 7,716 shares during the period. Capital Research Global Investors’ holdings in CME Group were worth $290,105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Asset Dedication LLC increased its stake in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new position in CME Group in the fourth quarter worth about $27,000. Legacy Wealth Managment LLC ID raised its position in CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. Global Wealth Strategies & Associates raised its position in CME Group by 1,250.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 100 shares in the last quarter. Finally, Anfield Capital Management LLC raised its position in CME Group by 197.4% in the fourth quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 75 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of several recent research reports. Keefe, Bruyette & Woods initiated coverage on shares of CME Group in a research report on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price target for the company. Jefferies Financial Group dropped their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research report on Thursday, April 9th. Rothschild & Co Redburn dropped their price target on shares of CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. Argus reissued a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Finally, Piper Sandler increased their price target on shares of CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $305.29.

Insiders Place Their Bets

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 44,044 shares of company stock valued at $13,297,507. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of NASDAQ CME opened at $257.40 on Monday. The firm’s 50-day simple moving average is $288.35 and its 200 day simple moving average is $288.67. The company has a market cap of $93.27 billion, a price-to-earnings ratio of 21.96, a price-to-earnings-growth ratio of 2.88 and a beta of 0.21. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.80 EPS. On average, research analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.